Medicale Corp (MCLE)

USD 0.15

(1.27%)

EBITDA Summary of Medicale Corp

  • Medicale Corp's latest annual EBITDA in 2023 was -37.59 Thousand USD , up 14.6% from previous year.
  • Medicale Corp's latest quarterly EBITDA in 2024 Q1 was -19.31 Thousand USD , down -35.71% from previous quarter.
  • Medicale Corp reported an annual EBITDA of -44.01 Thousand USD in 2022, down -47.95% from previous year.
  • Medicale Corp reported an annual EBITDA of -29.75 Thousand USD in 2021, down -1449.58% from previous year.
  • Medicale Corp reported a quarterly EBITDA of -9290.00 USD for 2024 Q3, down 0.0% from previous quarter.
  • Medicale Corp reported a quarterly EBITDA of -10.6 Thousand USD for 2024 Q2, up 100.0% from previous quarter.

Annual EBITDA Chart of Medicale Corp (2023 - 2020)

Historical Annual EBITDA of Medicale Corp (2023 - 2020)

Year EBITDA EBITDA Growth
2023 -37.59 Thousand USD 14.6%
2022 -44.01 Thousand USD -47.95%
2021 -29.75 Thousand USD -1449.58%
2020 21.15 Thousand USD 0.0%

Peer EBITDA Comparison of Medicale Corp

Name EBITDA EBITDA Difference
AiXin Life International, Inc. -2.08 Million USD 98.2%
Energroup Holdings Corp. 12.09 Million USD 100.311%
Green PolkaDot Box Incorporated - USD Infinity%
Innovative Food Holdings, Inc. -2.64 Million USD 98.581%
Nascent Wine Company, Inc. -3.86 Million USD 99.028%
Natural Harmony Foods, Inc. - USD Infinity%
NXT Nutritionals Holdings, Inc. -4.44 Million USD 99.155%
Pacific Ventures Group, Inc. -2.56 Million USD 98.537%
Verus International, Inc. - USD Infinity%
Wanderport Corporation -9790.00 USD -283.994%